Christopher J. Williams - 30 Sep 2024 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
30 Sep 2024
Net transactions value
+$32,419
Form type
4
Filing time
02 Oct 2024, 18:35:57 UTC
Previous filing
31 Jul 2024
Next filing
03 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $32,419 +199 +44% $162.91 649 30 Sep 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +131 +0.77% $0.000000 17,130 30 Aug 2024 Common Stock 131 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of quarterly director's fee.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.